stockrow
Tuesday 3 November 2026
Export UNH’s income statement to Excel — free account
UnitedHealth Group Incorporated
UNH Healthcare Healthcare Plans
UnitedHealth Group Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $447.6 billion, up 11.8% from fiscal 2024.
- Revenue
- −0.41%
- EPS
- +76.1%
- Free cash flow
- −15.7%
- Total debt
- −5.09%
Quarter to September 2026, against a year earlier
399.68
0.76
−0.19%
Follow UNH
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
| 0.00% | 13.78% | 11.77% | 12.16% |
+8 more TTM periods Free account |
|
Piotroski F-Score |
— | 6 | 6 | 6 | |
| 5.06% | 4.57% | 3.87% | 3.97% | ||
ROIC |
10.36% | 9.50% | 8.17% | 8.21% | |
Return on Tangible Assets |
(18.20%) | (99.46%) | (97.68%) | (88.95%) | |
Average Days of Receivables |
16.68 | 37.54 | 41.54 | 42.99 | |
Free Cash Flow per Share |
0.00 | 26.18 | 21.66 | 17.70 | |
Free Cash Flow |
22,826.00 | 23,617.00 | 19,666.00 | 16,075.00 | |
Capital Expenditures |
(3,369.00) | (3,400.00) | (3,487.00) | (3,622.00) | |
| Other line items | |||||
Cash ROIC |
11.33% | 11.49% | 9.52% | 8.02% | |
Accounts Receivable Turnover |
11.84 | 9.09 | 8.64 | 8.85 | |
Accounts Payable Turnover |
0.00 | 9.78 | 10.12 | 10.08 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 40.04 | 38.61 | 38.07 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.16) | (0.14) | (0.12) | (0.13) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.23% | 0.23% | 0.21% | 0.22% | |
Interest Coverage |
6.21 | 5.57 | 4.76 | 4.74 | |
Operating CF/Net income |
1.65 | 1.91 | 1.92 | 1.63 | |
Depreciation/Fixed assets |
0.00 | 0.40 | 0.41 | 0.41 | |
Capex/Depreciation |
(0.79) | (0.79) | (0.81) | (0.83) | |
Revenue per Share |
0.00 | 499.03 | 495.28 | 492.92 | |
Operating CF per Share |
0.00 | 29.95 | 25.50 | 21.69 | |
Capex per Share |
0.00 | (3.77) | (3.84) | (3.99) | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 |
Columns are period end dates · fundamentals updated 2 Nov 2026